Impressive long-term response with chemo-endocrine therapy in a premenopausal patient with metastatic breast cancer: A case report

RATIONALE: Patients with, or who develop, metastatic breast cancer have a 5-year relative survival of about 25%. Endocrine therapy clearly improves outcomes in patients with estrogen receptor-positive breast cancer. In the metastatic setting, the primary goal of treatment is to maintain long-term di...

Descripción completa

Detalles Bibliográficos
Autores principales: Maltoni, Roberta, Palleschi, Michela, Gallerani, Giulia, Bravaccini, Sara, Cecconetto, Lorenzo, Melegari, Elisabetta, Altini, Mattia, Rocca, Andrea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2020
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7302633/
https://www.ncbi.nlm.nih.gov/pubmed/32541460
http://dx.doi.org/10.1097/MD.0000000000020396

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7302633/
https://www.ncbi.nlm.nih.gov/pubmed/32541460
http://dx.doi.org/10.1097/MD.0000000000020396

Ejemplares similares